International Journal of Academic Health and Medical Research (IJAHMR)
  Year: 2022 | Volume: 6 | Issue: 1 | Page No.: 45-63
Uterine Sarcoma Download PDF
Errarhay Sanaa, Lahkim Bennani Aymen, Karam Saoud, Bouchikhi Chahrazed, Boubou Meriem, El Fatemi Hind, Banani Abdel Aziz

Abstract:
: Our study's aim was to evaluate the epidemiology, clinicopathological features, diagnosis difficulties, treatment and prognosis of uterine sarcomas. The retrospective study of eight cases of uterine sarcoma was conducted in the department of gynecology and obstetrics I, university hospital Hassan II, Fes. The age range of presentation was from 46 to 70 years. The main presenting symptoms and clinical signs present at diagnosis are vaginal bleeding, pelvic pain and pelvic mass. Imaging procedure consisted on ultrasonography in the eight cases, hysteroscopy with biopsy in 03 case, tomography in 01 cases and magnetic resonance imaging in 03 case. The diagnosis of leimyosarcoma was established preoperatively in one case through biopsy. All patients except the one, had first intention surgery, Postoperative pathohistologic analysis showed that leiomyosarcoma was present in 05 cases, endometrial sarcoma in 03 case. All patients were sent to the hospital of Oncology in Fez for additional treatment, 04 patients were lost to view, three patients benefited from adjuvant radiotherapy, the outcome was favorable for 02 patients, the other showed a recurrence 2 years after the initial diagnosis, they received palliative chemotherapy. Uterine sarcomas are a heterogeneous group of rare gynecological malignant neoplasms. Our finding about frequency of leiomyosarcoma (62,5%) correlate with curent data, followed by endometrial stromal sarcomas 37.5%. Generally diagnosis is established after surgery. Actually, the gold standard is hystero salpingo ovariectomy associated with postoperative radiotherapy. Place of chemotherapy is still discussed.